https://staging-250826.genovis.com/additives-co-factors/certain-n-glycosylation-sites-are-poorly-or-not-accessible-to-pngase-f-unless-the-substrate-protein-is-denatured/ 2023-02-01T12:15:08+00:00 https://staging-250826.genovis.com/additives-co-factors/remaining-n-glycans-after-incubation-on-the-omniglyzor-microspin-column-can-be-removed/ 2023-02-01T12:15:08+00:00 https://staging-250826.genovis.com/additives-co-factors/by-an-additional-deglycosylation-step-under-denaturing-conditions-using-the-lyophilized-pngase-f-and-rapigest-sf-surfactant-included-in-the-kit/ 2023-02-01T12:15:08+00:00 https://staging-250826.genovis.com/additives-co-factors/requires-the-presence-of-calcium-ions/ 2024-09-23T11:53:15+00:00 https://staging-250826.genovis.com/additives-co-factors/1-vial-20x-cacl2-solution-200mm-is-included/ 2024-09-23T11:53:15+00:00 https://staging-250826.genovis.com/additives-co-factors/requires-reducing-conditions/ 2025-05-28T12:39:06+00:00 https://staging-250826.genovis.com/additives-co-factors/cysteine-cysteamine-2-mercaptoethanol-dtt-tcep/ 2023-02-01T13:44:07+00:00 https://staging-250826.genovis.com/additives-co-factors/cysteine-dtt-tcep/ 2025-05-28T12:39:06+00:00 https://staging-250826.genovis.com/additives-co-factors/2-mm-cysteine-gingiskhan-reducing-agent-10x-included/ 2023-02-03T14:04:13+00:00 https://staging-250826.genovis.com/additives-co-factors/30-50-mm-cys-is-enough-for-activity-and-should-not-be-exceeded-when-intact-fab-fragments-are-required/ 2023-02-01T13:43:38+00:00 https://staging-250826.genovis.com/additives-co-factors/galt-requires-buffer-additive-for-activity/ 2023-02-03T14:01:14+00:00 https://staging-250826.genovis.com/additives-co-factors/buffer-additive-is-included-in-the-glyclick-kit/ 2023-02-03T14:01:14+00:00 https://staging-250826.genovis.com/additives-co-factors/optimal-activity-on-desialylated-sample-sialexo/ 2023-02-01T13:27:26+00:00 https://staging-250826.genovis.com/additives-co-factors/use-of-the-dtt-and-tcep-will-not-yield-intact-fab-fragments/ 2023-02-01T13:43:38+00:00